Analyst Ratings for [LH] Laboratory Corporation of America Holdings

3/4/25	Upgrades	Neutral Buy	X
LH Labcorp Holdings Inc. Citigroup
$250 $300
1/7/25	Upgrades	In-line Outperform	X
LH Labcorp Holdings Inc. Evercore ISI
$260 $265
12/10/24	Resumed	Buy	X
LH Labcorp Holdings Inc. Jefferies
$265 $275
10/30/24	Upgrades	Hold Buy	X
LH Labcorp Holdings Inc. HSBC Securities
10/1/24	Initiated	Neutral	X
LH Labcorp Holdings Inc. Piper Sandler
$235
3/25/24	Upgrades	Hold Buy	X
LH Laboratory Corp Argus
$250
2/26/24	Initiated	Outperform	X
LH Laboratory Corp Leerink Partners
$260
2/9/24	Initiated	In-line	X
LH Laboratory Corp Evercore ISI
$240
1/3/24	Initiated	Equal Weight	X
LH Laboratory Corp Barclays
$222
9/6/23	Initiated	Hold	X
LH Laboratory Corp HSBC Securities
$210
12/12/22	Downgrades	Buy Neutral	X
LH Laboratory Corp Citigroup
$275 $250
9/19/22	Downgrades	Buy Hold	X
LH Laboratory Corp Argus
8/22/22	Resumed	Overweight	X
LH Laboratory Corp Morgan Stanley
$300
1/11/21	Upgrades	Hold Buy	X
LH Laboratory Corp Argus
$245
1/11/21	Downgrades	Peer Perform Underperform	X
LH Laboratory Corp Wolfe Research
1/8/21	Downgrades	Outperform Peer Perform	X
LH Laboratory Corp Wolfe Research
7/16/19	Upgrades	Underperform Neutral	X
LH Laboratory Corp BofA/Merrill
6/21/19	Upgrades	Hold Buy	X
LH Laboratory Corp Deutsche Bank
$180 $220
4/2/19	Upgrades	Hold Buy	X
LH Laboratory Corp Jefferies
$154 $190
1/17/19	Initiated	Buy	X
LH Laboratory Corp UBS
$169
1/3/19	Downgrades	Neutral Underperform	X
LH Laboratory Corp BofA/Merrill
12/3/18	Downgrades	Buy Hold	X
LH Laboratory Corp Craig Hallum
10/30/18	Downgrades	Buy Hold	X
LH Laboratory Corp Argus
10/25/18	Downgrades	Buy Hold	X
LH Laboratory Corp Canaccord Genuity
$190 $162
6/7/18	Upgrades	Sec Weight Overweight	X
LH Laboratory Corp KeyBanc Capital Mkts
5/1/18	Upgrades	Neutral Outperform	X
LH Laboratory Corp Robert W. Baird
3/23/18	Initiated	Buy	X
LH Laboratory Corp Argus
$202
2/26/18	Reiterated	Overweight	X
LH Laboratory Corp Barclays
$195 $210

LH Laboratory Corporation of America Holdings

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.